We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CRISPR-Gold Fixes Duchenne Muscular Dystrophy Mutation in Mice

News   Oct 06, 2017 | Original story from UC Berkeley

 
CRISPR-Gold Fixes Duchenne Muscular Dystrophy Mutation in Mice

CRISPR–Gold is composed of 15 nanometer gold nanoparticles that are conjugated to thiol-modified oligonucleotides (DNA-Thiol), which are hybridized with single-stranded donor DNA and subsequently complexed with Cas9 and encapsulated by a polymer that disrupts the endosome of the cell. Credit: UC Berkeley

 
 
 

RELATED ARTICLES

No Cancer Risk for Telomerase Gene Therapy

News

Researchers from the Spanish National Cancer Research Centre (CNIO) have shown in a new study that the gene therapy with telomerase that they have developed, and which has proven to be effective in mice against diseases caused by excessive telomere shortening and ageing, does not cause cancer or increase the risk of developing it, even in a cancer-prone setting.

READ MORE

Identical Mutation, Different Symptoms: Researchers Outline 'Modified Penetrance' Hypothesis

News

Researchers have uncovered a molecular mechanism behind one of biology's long-standing mysteries: why individuals carrying identical gene mutations for a disease end up having varying severity or symptoms of the disease. I

READ MORE

Mouse Model Shows Gene Therapy Vectors Carrying Telomerase Gene Do Not Increase Cancer Risk

News

Gene therapy with telomerase was developed in 2012 and has proved effective in mice against infarction, as well as in mouse models of aplastic anaemia and idiopathic pulmonary fibrosis associated to short telomeres.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE